ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0119

Emergency Department Utilization by Persons with Inflammatory Arthritis Conditions Varies by Geographic Location of Residence

Cheryl Barnabe1, Patrick McLane2, Nadia Luca1, Kelsey Chomistek1, Meghan Elliott1, Shanon McQuitty3, Steven Katz2, Eileen Davidson3, Clare Hildebrandt4, Katie Lin1, Brian Holroyd2 and Claire Barber1, 1University of Calgary, Calgary, AB, Canada, 2University of Alberta, Edmonton, AB, Canada, 3Arthritis Research Canada, Vancouver, BC, Canada, 4Patient and Family Advisors, Alberta Health Services, Calgary, AB, Canada

Meeting: ACR Convergence 2022

Keywords: Access to care, gout, Health Services Research, Juvenile idiopathic arthritis, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Healthcare Disparities in Rheumatology Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Rheumatology services in Canada are largely restricted to urban centres, resulting in significant access difficulties for residents of rural and remote locations. As a result, some emergency department (ED) utilization by persons with inflammatory arthritis (IA) conditions may reflect deficiencies in current arthritis health service delivery models. Our objective was to characterize ED use by persons with IA conditions based on residence in an urban or rural location to inform required ambulatory care service enhancements.

Methods: Estimates of ED utilization were obtained from analyzing population-based data from a universal provincial health system in Alberta, Canada (~4.4 million residents). Validated case definitions were applied to physician claims and hospitalization administrative datasets (years 2002-2018) to create prevalent cohorts of persons with Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), Psoriatic Arthritis (PsA), gout and Juvenile Idiopathic Arthritis (JIA). Records were then linked to the National Ambulatory Care Reporting System dataset in which ED use is documented with details of presentation (timing, acuity, diagnosis, and disposition). Estimates were stratified by postal code for descriptive analysis; annual estimates for years 2008-2018 were generated to identify possible time trends, and data presented here are from fiscal year 2017-2018.

Results: There were 60,373 persons with an IA condition (15,320 rural) with 156,570 ED visits (52,739 rural) in the 2017-2018 fiscal year (Table 1). Those living in rural locations were significantly more likely to have at least 1 ED visit per year (difference RA 19.5%, PsA 18.3%, AS 20.5%, gout 19.3%, JIA 14.5%). For all conditions except JIA, an individual rural resident with an IA condition had nearly twice the annual mean number of visits to the ED compared to urban residents (all p< 0.01). A significantly higher number of visits by rural persons with IA conditions were triaged into less urgent and non-urgent acuity levels (all p< 0.01). Rural persons with IA conditions were significantly more likely to present to the ED during daytime hours (08:00-16:00 hours) than their urban counterparts, and for all conditions except JIA during a weekday (range 72-73% for rural vs 68-69%) rather than a weekend or holiday day. Lengths of stay in the ED were significantly shorter for rural persons with RA, PsA, AS and gout (range 197-230 minutes) than urban persons with these conditions (range 323-470 minutes). The frequency of return visits to the ED within 72 hours of the initial presentation was significantly higher in rural patients with RA (difference 8.9%; 95%CI 7.6, 10.3), PsA (difference 9.9%; 95%CI 5.4, 14.3), AS (difference 6.0%; 95%CI 3.7, 8.2), and Gout (difference 7.3%; 95%CI 6.2, 8.3). Rural patients were not significantly more likely to present to the ED for a flare of their IA condition.

Conclusion: The ED is an important health service access location for rural patients with IA conditions, although not directly related to their arthritis condition. Persons with JIA conditions and who are rural residents are potentially seeking ED care in urban centres.

Supporting image 1

Table 1. Emergency Department Use by Urban and Rural Patients with Inflammatory Arthritis Conditions in Alberta, Canada (fiscal year 2017_2018)

Supporting image 2

Figure 1. Diagnoses from Emergency Department Use by Rural and Urban Residents with Inflammatory Arthritis Conditions in Alberta, Canada (fiscal year 2017_2018, proportions)


Disclosures: C. Barnabe, Janssen, Fresenius Kabi, Celltrion Healthcare, Pfizer; P. McLane, None; N. Luca, None; K. Chomistek, None; M. Elliott, None; S. McQuitty, None; S. Katz, None; E. Davidson, None; C. Hildebrandt, None; K. Lin, None; B. Holroyd, None; C. Barber, None.

To cite this abstract in AMA style:

Barnabe C, McLane P, Luca N, Chomistek K, Elliott M, McQuitty S, Katz S, Davidson E, Hildebrandt C, Lin K, Holroyd B, Barber C. Emergency Department Utilization by Persons with Inflammatory Arthritis Conditions Varies by Geographic Location of Residence [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/emergency-department-utilization-by-persons-with-inflammatory-arthritis-conditions-varies-by-geographic-location-of-residence/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/emergency-department-utilization-by-persons-with-inflammatory-arthritis-conditions-varies-by-geographic-location-of-residence/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology